According to the bulk list data of SunSirs, the domestic market of PA6 continued to decline on November 22. The supply of caprolactam at the cost side increased, the price of caprolactam continued to be under pressure, and the support for PA6 market weakened. At present, the impact of domestic double limit and other environmental protection policies is still affecting the PA6 industry and its downstream load, and the demand follow-up is slow. The on-site wait-and-see mood is aggravated and the trading is poor. It is expected that the spot price of China PA6 may continue to be weak in the short term.

If you have any questions, please feel free to contact SunSirs with support@sunsirs.com.